Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1Breast 1

Conditions

Breast Neoplasms 8Prostatic Neoplasms 2Neoplasms 2Weight Loss 1Polyps 1Osteoporosis 1Myocardial Ischemia 1Myocardial Infarction 1Metabolic Syndrome 1Lung Neoplasms 1Heart Diseases 1Diabetes Mellitus 1Depression 1Coronary Disease 1Colonic Neoplasms 1Cognitive Dysfunction 1Cardiovascular Diseases 1Carcinoma, Renal Cell 1Bone Diseases 1Body Weight Changes 1Angina, Unstable 1Adenoma 1

Interventions

Zoledronic Acid 16Risedronic Acid 9Vitamin D 8Calcium 8Letrozole 7Absorptiometry, Photon 6Cholecalciferol 5Calcium Carbonate 5Alendronate 5Denosumab 4Calcium Gluconate 3parathyroid hormone-related peptide (1-36) 2bicalutamide 2Resistance Training 2Progesterone 2Nutrition Assessment 2Kyphoplasty 2Hormone Replacement Therapy 2Goserelin 2Estradiol 2Calcium Citrate 2Aromatase Inhibitors 2Anastrozole 2xian ling gu bao 1romosozumab 1X-Rays 1Toremifene 1Testosterone 1Technetium 1Spectrum Analysis 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Osteoporosis × Diet, Fat-Restricted × Clear all
NCT00000611 2016-04-15

Women's Health Initiative (WHI)

National Heart, Lung, and Blood Institute (NHLBI)

Phase 3 Completed
BreastGastrointestinal

Bone Diseases, Breast Neoplasms, Cardiovascular Diseases, Colonic Neoplasms, Coronary Disease, Heart Diseases, Osteoporosis, Myocardial Ischemia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡